Identifying risk factors for prolonged transfusion-dependent temozolomide-induced thrombocytopaenia in patients receiving concurrent chemo-radiotherapy for glioblastoma (gbm)
Affiliation
The Christie NHS FT, Manchester, Manchester,Issue Date
2022
Metadata
Show full item recordCitation
Ismail N, Patel K, Parikh T, Colaco R, McBain C. Identifying Risk Factors for Prolonged Transfusion-Dependent Temozolomide-Induced Thrombocytopaenia in Patients Receiving Concurrent Chemo-Radiotherapy for Glioblastoma (Gbm). Neuro-oncology. 2022 Nov;24:235-6. PubMed PMID: WOS:000888571001223.Journal
Neuro-OncologyDOI
10.1093/neuonc/noac209.909Additional Links
https://dx.doi.org/10.1093/neuonc/noac209.909Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/neuonc/noac209.909